F2 and Congenital factor II deficiency: The authors postulated that the development of autoantibodies targeting prothrombin (factor II), a vital protein in the coagulation cascade responsible for thrombin generation, can lead to accelerated clearance or functional inhibition of prothrombin, resulting in hypoprothrombinemia [5].